Adjuvant Chemotherapy With Pemetrexed and Cisplatin vs. Vinorelbine and Cisplatin in NSCLC IB, IIA, IIB, T3N1: a Randomized Phase II Study.

Trial Profile

Adjuvant Chemotherapy With Pemetrexed and Cisplatin vs. Vinorelbine and Cisplatin in NSCLC IB, IIA, IIB, T3N1: a Randomized Phase II Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Sep 2014

At a glance

  • Drugs Pemetrexed (Primary) ; Cisplatin; Vinorelbine
  • Indications Non-small cell lung cancer
  • Focus Adverse reactions
  • Acronyms TREAT
  • Most Recent Events

    • 08 Sep 2014 Efficacy results presented at the 24th Annual Congress of the European Respiratory Society.
    • 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
    • 12 Jul 2011 New source identified and integrated (European Clinical Trials Database)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top